Biopeptide (United States)

Recent papers from Biopeptide (United States)

1. Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespanJournal of Translational Medicine · 2026
2. Transcriptomic profiling of the ovarian immune landscape reveals distinct macrophage subsets and activation of the NLRP3 inflammasome likely contributing to accelerated follicular atresia in classic galactosemiaCell Communication and Signaling · 2026
3. Bioassay-Guided Isolation and Herbicidal Activity Evaluation of Phytochemicals from Abelia grandifloraACS Agricultural Science & Technology · 2025
4. Design, Synthesis, and Biological Activity of Novel Thiazole Sulfonamide Derivatives as Potent Fungicide Candidates against Sclerotinia sclerotiorumJournal of Agricultural and Food Chemistry · 2025
5. Biom-03 the Oncogenic Flip in Patients With Leptomeningeal Metastatic Disease (Lmd): Longitudinal Detection in Cerebrospinal Fluid Tumor Cells (Csf-Tcs) Reveals Implications for Differential Treatment of the LMD TumorNeuro-Oncology Advances · 2025
6. Tumor Necrosis Factor Receptors and C-C Chemokine Receptor-2 Positive Cells Play an Important Role in the Intraerythrocytic Death and Clearance of Babesia microtiPathogens · 2024
7. BMRK-02 Prognostic Value of Cerebrospinal Fluid Tumor Cell Count in Leptomeningeal Disease From Solid TumorsNeuro-Oncology Advances · 2024
8. BMRK-12 the Cnside CSF Tumor Cell Detection Platform Is a Feasible, Clinically Relevant and Scalable Platform for Disease Management for Patients With Leptomeningeal DiseaseNeuro-Oncology Advances · 2024
9. A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal MetastasesArchives of Pathology & Laboratory Medicine · 2024
10. The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapyFrontiers in Oncology · 2024
11. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors2024
12. Keeping a track on leptomeningeal disease in non–small cell lung cancer: A single-institution experience with CNSideTMNeuro-Oncology Advances · 2023
13. Single-tier point-of-care serodiagnosis of Lyme disease2023
14. Linear Peptide Epitopes Derived from ErpP, p35, and FlaB in the Serodiagnosis of Lyme DiseasePathogens · 2022
15. BIOM-05. CASE SERIES OF MULTI-INSTITUTIONAL UTILITY OF CNSide TO MANAGE LEPTOMENINGEAL DISEASE IN PATIENTS WITH METASTATIC BREAST CANCERNeuro-Oncology · 2021
16. PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsJournal of Experimental & Clinical Cancer Research · 2021
17. Detection of IFN-γ Secretion in Blood Samples Collected Before and After Treatment of Varying Stages of Lyme DiseaseClinical Infectious Diseases · 2021
18. Formaldehyde in multicomponent reactionsGreen Chemistry · 2021
19. BBrowser: Making single-cell data easily accessible2020
20. Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detectionJournal of Clinical Pathology · 2020